Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

187.50p
   
  • Change Today:
      2.50p
  • 52 Week High: 262.50
  • 52 Week Low: 141.67
  • Currency: UK Pounds
  • Shares Issued: 116.95m
  • Volume: 12,592
  • Market Cap: £219.29m
  • Beta: 0.01

FARN Overview

We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.

Key Personnel

CEO: Juho Jalkanen
CFO: Yrjö E K Wichmann
Chairman: Tuomo Pätsi
Director: Markku Jalkanen
Independent Non-Executive Director: John Poulos
Non-Executive Dir: Colin Bond , Marie-Louise Fjällskog, Christine Roth

Contact Details

Address: Joukahaisenkatu 6, Turku, Finland, FI-20520
Phone: +358 2 469 5151
Fax: +358 2 469 5152
Website: http://www.faronpharmaceuticals.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: FI4000153309

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

FARN Market Data

Currency UK Pounds
Share Price 187.50p
Change Today 2.50p
% Change 1.35 %
52 Week High 262.50
52 Week Low 141.67
Volume 12,592
Shares Issued 116.95m
Market Cap £219.29m
Beta 0.01

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 1
Strong Sell 1
Total 6
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

FARN Dividends

No dividends found

Trades for 18-Sep-2025

Time Volume / Share Price
15:25 500 @ 185.10p
15:16 500 @ 185.10p
10:21 51 @ 194.40p
08:18 10,212 @ 188.40p
09:00 500 @ 185.10p

FARN Key Personnel

CFO Yrjö E K Wichmann
CEO Juho Jalkanen
Chair Tuomo Pätsi

Top of Page